Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Hosted content
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Hosted content
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 65, Issue 3
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
XML
Hepatology
Original article
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein
Online download statistics by month:
Online download statistics by month: February 2015 to March 2024
Abstract
Full
Pdf
Feb 2015
387
670
147
Mar 2015
249
173
99
Apr 2015
85
104
67
May 2015
62
88
50
Jun 2015
69
82
28
Jul 2015
48
77
34
Aug 2015
54
58
35
Sep 2015
72
68
28
Oct 2015
30
53
23
Nov 2015
47
74
34
Dec 2015
187
48
31
Jan 2016
75
70
38
Feb 2016
701
114
81
Mar 2016
410
106
74
Apr 2016
247
181
34
May 2016
140
65
46
Jun 2016
80
80
42
Jul 2016
67
63
36
Aug 2016
109
53
43
Sep 2016
92
48
27
Oct 2016
122
61
26
Nov 2016
83
63
27
Dec 2016
87
50
28
Jan 2017
82
43
14
Feb 2017
20
35
19
Mar 2017
17
53
21
Apr 2017
22
85
25
May 2017
25
100
31
Jun 2017
36
69
36
Jul 2017
99
78
34
Aug 2017
136
95
27
Sep 2017
117
83
28
Oct 2017
130
104
30
Nov 2017
123
81
25
Dec 2017
126
84
39
Jan 2018
409
373
31
Feb 2018
132
81
24
Mar 2018
271
225
31
Apr 2018
286
248
34
May 2018
165
137
20
Jun 2018
157
130
33
Jul 2018
151
103
33
Aug 2018
145
111
25
Sep 2018
157
113
30
Oct 2018
230
192
26
Nov 2018
269
219
38
Dec 2018
199
171
16
Jan 2019
190
154
25
Feb 2019
202
163
43
Mar 2019
132
100
43
Apr 2019
125
83
31
May 2019
106
73
35
Jun 2019
64
46
27
Jul 2019
93
57
36
Aug 2019
105
81
17
Sep 2019
107
83
26
Oct 2019
79
53
25
Nov 2019
108
80
28
Dec 2019
103
77
17
Jan 2020
102
82
23
Feb 2020
101
90
22
Mar 2020
86
76
21
Apr 2020
73
61
22
May 2020
54
44
15
Jun 2020
89
73
40
Jul 2020
34
29
6
Aug 2020
21
19
11
Sep 2020
58
51
8
Oct 2020
76
64
12
Nov 2020
48
44
21
Dec 2020
57
42
20
Jan 2021
32
30
18
Feb 2021
57
45
20
Mar 2021
77
67
30
Apr 2021
34
32
6
May 2021
56
56
17
Jun 2021
58
58
20
Jul 2021
29
29
21
Aug 2021
23
22
16
Sep 2021
33
33
11
Oct 2021
44
32
27
Nov 2021
50
40
29
Dec 2021
40
36
13
Jan 2022
46
38
29
Feb 2022
30
27
11
Mar 2022
47
42
18
Apr 2022
44
39
18
May 2022
56
49
29
Jun 2022
105
55
15
Jul 2022
41
29
9
Aug 2022
50
42
18
Sep 2022
45
38
36
Oct 2022
46
42
19
Nov 2022
28
29
13
Dec 2022
35
30
7
Jan 2023
44
41
9
Feb 2023
57
57
18
Mar 2023
63
46
28
Apr 2023
41
37
24
May 2023
44
29
16
Jun 2023
19
17
10
Jul 2023
47
46
20
Aug 2023
30
30
15
Sep 2023
164
158
13
Oct 2023
907
894
12
Nov 2023
1013
1010
6
Dec 2023
231
230
128
Jan 2024
71
68
178
Feb 2024
51
51
19
Mar 2024
40
40
47
Total
13148
10881
3315
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?